Gefitinib 184475-35-2
-
Post Date:
May 07,2019
-
Expiry Date:
Nov 03,2019
-
Detailed Description:
Cas No. :184475-35-2
Gefitinib is a drug used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR. However, meta-analyses have not shown any improvement in overall survival, that is, it does not extend life.
-
CAS Registry Number:
184475-35-2
-
Synonyms:
;GEFITINIB;AKOS 91371;n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;ZD 1839;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-;Gefitinib(TINIBS);Gefitinib, Iressa, ZD1839;Gefitinib Base;Geftinib;
-
Molecular Formula:
C22H24ClFN4O3
-
Molecular Weight:
446.9024
-
Molecular Structure:
Inquiry